BRANDICOURT OLIVIER 4
4 · Vaxcyte, Inc. · Filed Jan 16, 2026
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
BRANDICOURT OLIVIER
Director
Transactions
- Award
Common Stock
[F1]2026-01-15+1,357→ 2,505 total - Award
Stock Option (right to buy)
[F2]2026-01-15+6,750→ 6,750 totalExercise: $48.04Exp: 2035-06-12→ Common Stock (6,750 underlying)
Footnotes (2)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
- [F2]The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
Signature
Olivier Brandicourt, by /s/ Peter N. Efremenko, Attorney-In-Fact|2026-01-16